Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Asia Congress 2022

Ipsen - Exploring optimal management and treatment sequencing in NSCLC, HCC and RCC

What’s new in the management of non-mutated NSCLC after progression to immunotherapy treatment

Date

02 Dec 2022

Session

Ipsen - Exploring optimal management and treatment sequencing in NSCLC, HCC and RCC

Topics

Tumour Site

Non-Small Cell Lung Cancer

Presenters

Solange Peters

Authors

S. Peters

Author affiliations

  • Oncology Dept., CHUV - Centre Hospitalier Universitaire Vaudois, 1011 - Lausanne/CH

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

Welcome and opening

Presenter: Hwai Loong Kong

Session: Ipsen - Exploring optimal management and treatment sequencing in NSCLC, HCC and RCC

Resources:

Webcast

Current management of NSCLC in Asia Pacific

Presenter: Thanyanan Baisamut (Reungwetwattana)

Session: Ipsen - Exploring optimal management and treatment sequencing in NSCLC, HCC and RCC

Resources:

Webcast

Panel discussion and closing

Presenter: Solange Peters

Session: Ipsen - Exploring optimal management and treatment sequencing in NSCLC, HCC and RCC

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.